pyrazines has been researched along with Polyomavirus Infections in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Arthur, J; Conti, DJ; Friedrich, TD; Hainley, LE; Hayner-Buchan, A; Hughson, MS; Lehman, JM; Narendran, A; Smith, R | 1 |
| Basu, A; Humar, A; Lunz, J; Mapara, M; Randhawa, P; Shapiro, R; Sharma, V; Tan, HP; Zeevi, A | 1 |
| Arora, R; Brodsky, JL; Chang, Y; Dömling, A; Feng, H; Guastafierro, A; Moore, PS; Normolle, D; Shuda, M; Tolstov, Y; Toptan, T; Vogt, A; Vollmer, LL | 1 |
3 other study(ies) available for pyrazines and Polyomavirus Infections
| Article | Year |
|---|---|
Chk1 and the Host Cell DNA Damage Response as a Potential Antiviral Target in BK Polyomavirus Infection.
Topics: BK Virus; Cells, Cultured; Checkpoint Kinase 1; DNA Damage; DNA Repair; Humans; Kidney; Kidney Transplantation; Phenylurea Compounds; Polyomavirus Infections; Pyrazines; Tumor Virus Infections; Virus Replication | 2021 |
1.7 year follow-up after bortezomib therapy for refractory antibody mediated rejection.
Topics: BK Virus; Boronic Acids; Bortezomib; Female; Graft Rejection; Graft Survival; HLA Antigens; Humans; Immunity, Humoral; Immunosuppressive Agents; Isoantibodies; Kidney Transplantation; Middle Aged; Polyomavirus Infections; Protease Inhibitors; Proteasome Endopeptidase Complex; Proteasome Inhibitors; Pyrazines; Time Factors; Treatment Outcome | 2010 |
Survivin is a therapeutic target in Merkel cell carcinoma.
Topics: Animals; Antigens, Viral, Tumor; Antineoplastic Agents; Base Sequence; Boronic Acids; Bortezomib; Carcinoma, Merkel Cell; Cell Line, Tumor; Female; Gene Expression Profiling; Humans; Imidazoles; Inhibitor of Apoptosis Proteins; Merkel cell polyomavirus; Mice; Mice, Inbred NOD; Mice, SCID; Naphthoquinones; Polyomavirus Infections; Pyrazines; RNA, Messenger; RNA, Neoplasm; Survivin; Translational Research, Biomedical; Tumor Virus Infections; Xenograft Model Antitumor Assays | 2012 |